Literature DB >> 12213217

Suppression of anchorage-independent growth of human cancer cell lines by the TRIF52/periostin/OSF-2 gene.

Naohisa Yoshioka1, Shigeo Fuji, Misuzu Shimakage, Ken Kodama, Akira Hakura, Masuo Yutsudo, Hirokazu Inoue, Hiroshi Nojima.   

Abstract

In searching for genes that suppress the viral transformation of primary cells, we have isolated a number of TRIF (transcript reduced in F2408) genes that are expressed well in primary rat embryo fibroblasts (REFs) but poorly in spontaneously immortalized rat fibroblast cell lines derived from REFs. One of these genes, TRIF52, is a rat homologue of the mouse protein periostin, which is suspected of being involved in oncogenesis. We found here that periostin mRNA expression is markedly downregulated in a variety of human cancer cell lines and human lung cancer tissues. Human cancer cell lines with reduced endogenous periostin gene expression that were infected with a recombinant retrovirus containing the periostin gene had reduced anchorage-independent growth. Mutational analysis revealed that the C-terminal region of periostin is sufficient to convey the anchorage-independent growth-suppressive activity of the protein. These observations together suggest that periostin may serve to inhibit the development of human cancers by acting as a tumor suppressor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12213217     DOI: 10.1006/excr.2002.5590

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  24 in total

1.  Role of TNF alpha and PLF in bone remodeling in a rat model of repetitive reaching and grasping.

Authors:  Shobha Rani; Mary F Barbe; Ann E Barr; Judith Litivn
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

2.  Metastatic outgrowth encompasses COL-I, FN1, and POSTN up-regulation and assembly to fibrillar networks regulating cell adhesion, migration, and growth.

Authors:  Johanna Soikkeli; Piotr Podlasz; Miao Yin; Pirjo Nummela; Tiina Jahkola; Susanna Virolainen; Leena Krogerus; Päivi Heikkilä; Karl von Smitten; Olli Saksela; Erkki Hölttä
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

Review 3.  Role of periostin and its antagonist PNDA-3 in gastric cancer metastasis.

Authors:  Guo-Xiao Liu; Hong-Qing Xi; Xiao-Yan Sun; Bo Wei
Journal:  World J Gastroenterol       Date:  2015-03-07       Impact factor: 5.742

Review 4.  The wound healing, chronic fibrosis, and cancer progression triad.

Authors:  Brad Rybinski; Janusz Franco-Barraza; Edna Cukierman
Journal:  Physiol Genomics       Date:  2014-02-11       Impact factor: 3.107

5.  Expression of periostin and its clinicopathological relevance in gastric cancer.

Authors:  Jun-Sheng Li; Guang-Wen Sun; Xiao-Ying Wei; Wen-Hao Tang
Journal:  World J Gastroenterol       Date:  2007-10-21       Impact factor: 5.742

6.  Incorporation of tenascin-C into the extracellular matrix by periostin underlies an extracellular meshwork architecture.

Authors:  Isao Kii; Takashi Nishiyama; Minqi Li; Ken-Ichi Matsumoto; Mitsuru Saito; Norio Amizuka; Akira Kudo
Journal:  J Biol Chem       Date:  2009-11-03       Impact factor: 5.157

7.  Induction of periostin-like factor and periostin in forearm muscle, tendon, and nerve in an animal model of work-related musculoskeletal disorder.

Authors:  Shobha Rani; Mary F Barbe; Ann E Barr; Judith Litvin
Journal:  J Histochem Cytochem       Date:  2009-07-20       Impact factor: 2.479

8.  Periostin-like-factor and Periostin in an animal model of work-related musculoskeletal disorder.

Authors:  Shobha Rani; Mary F Barbe; Ann E Barr; Judith Litvin
Journal:  Bone       Date:  2008-11-27       Impact factor: 4.398

9.  Characterization of a novel periodontal ligament-specific periostin isoform.

Authors:  S Yamada; T Tauchi; T Awata; K Maeda; T Kajikawa; M Yanagita; S Murakami
Journal:  J Dent Res       Date:  2014-07-10       Impact factor: 6.116

10.  Periostin shows increased evolutionary plasticity in its alternatively spliced region.

Authors:  Sebastian Hoersch; Miguel A Andrade-Navarro
Journal:  BMC Evol Biol       Date:  2010-01-28       Impact factor: 3.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.